More than one in 10 women may experience serious complications, such as hemorrhaging or severe infection, from medication abortions, according to a large-scale study published Monday. 

The new study, published by the anti-abortion Ethics and Public Policy Center, examined insurance claims data from over 865,000 mifepristone prescriptions from 2017 to 2023 and found that nearly 11% of women experience a potentially life-threatening complication within 45 days of a mifepristone abortion.